Calidi Biotherapeutics, Inc. (CLDI)
AMEX·Healthcare·Biotechnology
$1.26
-3.82%
Mkt Cap $2.62M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.50
Range $2.00 – $9.00
Implied Upside
+336.5%
Consensus $5.50 vs current $1.26
AMEX·Healthcare·Biotechnology
$1.26
-3.82%
Mkt Cap $2.62M
No recent rating data.
Price Target (2 analysts)
$5.50
Range $2.00 – $9.00
+336.5%
Consensus $5.50 vs current $1.26